Chamber and committees

We are aware that the percentage of eligible young people holding cards providing free bus travel under the new Young Persons’ Scheme varies between local authorities. There will be a variety of reasons for this, including different levels of local awareness and interest in the scheme and also variations in how different local authorities handle applications which come to them rather than through the national online portal, getyournec.scot, and Transport Scotland’s Pass Collect app (for people between 16 and 21 who already possess an active NEC or Young Scot NEC card). We estimate that the number of cards produced and dispatched for South Lanarkshire as of 19 April 2022 represented 14% of the eligible population.

We are working with our delivery partners, including the Improvement Service and local authorities, to identify and support improvements to both online and offline processes to maximise the uptake of scheme and get cards issued faster. One such measure, which we are encouraging, is to coordinate applications through schools on behalf of pupils. Some authorities are already doing this, including – we understand – South Lanarkshire for pupils moving up to secondary school.

I refer the member to the answer to question S6W-07156 on 28 March 2022. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

We published our Test and Protect Transition Plan on 15 March 2022. This states that from mid-April in place of a population wide approach, we will use asymptomatic testing for COVID-19 on a targeted basis. This includes testing to support patient care and protect higher risk settings.

Regular asymptomatic testing will continue for parts of the health and care workforce primarily in settings which are still considered high risk and/or where those using services are deemed to be at a higher risk of hospitalisation from COVID-19.

In social care, the priority will continue to be testing in long stay settings and services for elderly people such as residential care homes, care at home and adult day care. There will also be a continuing priority to support testing for hospital based staff to reduce the risk of infection spread in our hospitals.

LFD tests will continue to be made available for eligible unpaid carers, personal assistants and anyone visiting a care home or hospital, this will be kept under regular clinical review.

For any purpose for which COVID-19 testing (PCR or LFD) continues to be advised we will ensure that these tests remain available free of charge.

Data from the Renewable Energy Planning Database shows that there are 322 operational wind onshore projects and 7 operational wind offshore projects over 150kW in Scotland. Projects under this threshold are not captured.

There is currently no requirement to monitor drinking water for Perfluoroalkyl and polyfluoroalkyl substances (PFAS). However, such monitoring will become mandatory once new Regulations take effect in early 2023 to align with the requirements of the EU’s recast Drinking Water Directive.

There is currently no requirement to monitor drinking water for Perfluoroalkyl and polyfluoroalkyl substances (PFAS).However, such monitoring will become mandatory once new Regulations take effect in early 2023 to align with the requirements of the EU’s recast Drinking Water Directive. There are currently no plans to offer blood tests for PFAS.

In order to raise awareness of the early signs and symptoms of cancer, including ovarian cancer, a symptom-checker tool is included on our public facing website, getcheckedearly.org. An ovarian cancer survivor’s story and a link to the ovarian cancer page on Detect Cancer Early’s (DCE) website will be shared on our wee c social media pages, as part of Ovarian Cancer Awareness Month.

The NHS Recovery Plan – published August 2021 – commits an additional £20m for the DCE Programme, to provide greater public awareness of possible signs and symptoms of cancer and supporting the development of optimal cancer pathways to improve earlier diagnosis rates. Research is currently being undertaken to better understand the possible barriers and levers to early diagnosis that any new DCE campaigns should focus on.

Through the development of the Scottish Intercollegiate Guidelines Network (SIGN) guidelines on chronic pain in adults and children and young people , Scotland has been a world-leader in promoting evidence-based approaches for healthcare professionals to improve standards of care and management of chronic pain.

The Programme for Government 2020-21 committed to developing and publishing a new Framework for Chronic Pain Service Delivery. A draft Framework was published for public consultation and the responses are currently being analysed. We will publish our response to the findings, including how these views have been used to shape the final Framework, later this year.

The draft Framework sets out the Scottish Government’s aim to ensure that people have a choice of treatments for chronic pain, where there is evidence they are effective, underpinned by commitments to support patients and healthcare professionals to better understand and agree effective options to manage pain. This is intended to lead to less variation in the quality and availability of services for people with chronic pain.

As part of implementation of the Framework, we will explore opportunities to update the existing guidelines to ensure they reflect the most recent evidence and best practice, including offering new treatments where there is evidence that they are effective.

Dry powder inhalers(DPIs) make up 33% of the total in Scotland in primary care. In the last financial year (2020/2021), there were 4.5 million metered dose and 2.3 million dry powdered packs prescribed and dispensed via primary care and we have not seen a clear trend of those numbers changing and inverting.

Effectiveness of a powdered drug depends on a number of factors, including the inspiratory flow rate generated by the patient. For a significant proportion of patents, making the switch to a DPI will be successful, however, for some a DPI will not be suitable e.g. those with significantly impaired breathing. We would advocate regular medication reviews between the patient and GP at which time consideration should be given to switching to a DPI if deemed suitable for the individual patient’s circumstances

We recognise that hydrofluorocarbons used as propellant in metered dose inhalers prescribed for asthma and chronic obstructive pulmonary disease (COPD) can have a global warming potential of 1430 or 3220 times greater than CO2 depending on the type of gas used. Reducing the environmental impact of these inhalers is a priority.

A draft NHS Scotland Climate Emergency and Sustainability Strategy was published on 10 November 2021 and the consultation closed on 10 March 2022. This sets out the Scottish Government’s intention to publish an updated Scottish Quality Respiratory Prescribing guide which will focus on minimising patient over-use of inhalers through review and improving patient outcomes, using propellant free options where possible.

Other actions within the draft strategy include encouraging manufacturers to make inhalers with lower emissions and to support inhaler return to pharmacy schemes to help patients dispose of their used inhalers in a more environmentally friendly way.

Ministers have not visited any care homes in their official capacity during the COVID-19 pandemic, but have closely monitored the situation throughout. Both the Cabinet Secretary for Health and Social Care and myself took office in May 2021, partway through the pandemic.

I was previously scheduled to undertake two care home visits, however these had to be postponed for safety reasons due to a COVID outbreak and the emergence of the SARS-CoV-2 variant Omicron. The safety and protection of residents and staff is paramount in such situations. In my role as lead for Social Care policy, I have regularly spoken to a range of stakeholders from the sector including family and sector representatives. I have also spoken to care home staff and managers. I will be rescheduling care home visits in due course.

Of the professional advisers:

• the National Clinical Director, last visited a Glasgow Care Home on 21 st February 2021 and prior to the pandemic made a visit to a care home in October 2019;
• the Chief Social Work Adviser has not visited any care homes in her official capacity during the pandemic. Prior to the pandemic she visited David Walker Gardens care home in Rutherglen on 5 th August 2019;
• the Chief Medical Officer, who was appointed in December 2020, has not visited any care homes in his official capacity during the pandemic.